Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding

Hepatology

Volumn 48, Issue 2, 2008, Pages 580-587

  Lo, Gin Ho ^a   Chen, Wen Chi ^a   Lin, Chiun Ku ^a   Tsai, Wei Lun ^a   Chan, Hoi Hung ^a   Chen, Tai An ^a   Yu, Hsien Chung ^a   Hsu, Ping I ^a   Lai, Kwok Hung ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ISOSORBIDE 5 NITRATE; LAMIVUDINE; NADOLOL; TETRADECYL SULFATE SODIUM;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; BRAIN DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DOSE INCREASE; DYSPHAGIA; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSTERNAL PAIN; SURVIVAL RATE; TREATMENT RESPONSE; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRUG THERAPY, COMBINATION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; ISOSORBIDE DINITRATE; KAPLAN-MEIERS ESTIMATE; LIGATION; MALE; MIDDLE AGED; NADOLOL; RECURRENCE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 49649091096     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22358     Document Type: Article

References (21)

1. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-748.
2. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003;38:s54-s68.
3. Lo GH. Prevention of esophageal variceal rebleeding. J Chin Med Assoc 2006;9:53-60.
4. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and va-riceal hemorrhage. HEPATOLOGY 2007;46:922-938.
5. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Eno J Med 1992;326:1527-1532.
6. Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119:1-7.
7. Garcia-Pagan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodes J. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. HEPATOLOGY 1990;11:230-238.
8. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. HEPATOLOGY 2000;31:1239-1245.
9. Villanueva C, Minyana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal rebleeding. N Engl J Med 2001;345:647-655.
10. Lo GH, Chen WC, Chen MH, Hsu PI, Lin CK, Tsai WL, et al. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002;123:728-734.
11. Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-1019.
12. Romero G, Kravetz D, Argonz J, Vulcano C, Suarez A, Fassio E, et al. Nadolol plus isosorbide mononitrate compared with banding plus low volume sclerotherapy for prevention of variceal rebleeding in patients with cirrhosis. HEPATOLOGY 2004;40(Suppl 1):204A.
13. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial. HEPATOLOGY 1998;28:391-395.
14. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. J Hepatol 1997;26:312-324.
15. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. HEPATOLOGY 1995;22:466-471.
16. Hou MC, Lin HC, Kuo BIT, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. HEPATOLOGY 1995;21:1517-1522.
17. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacologic treatment of portal hypertension and long-term prognosis of cirrhosis. HEPATOLOGY 2003;37:902-908.
18. Villanueva C, Lopez-Balaguer JM, Aracil C, Kolle L, Minana J, Soriano G, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2004; 40:757-765.
19. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. HEPATOLOGY 1997;25:1101-1104.
20. Lo GH, Liang HL, Lai KH, Chang CF, Hwu JH, Chen SM, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 1995;24:74-80.
21. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease: A randomized, single-blind, multicenter clinical trial. N Engl J Med 1991;324:1779-1784.